Robert Hoffman

Companies

• CytoDyn Inc.Chief financial officer May 22, 2025 to now¹
• Esperion TherapeuticsBoard member Apr 2, 2025 to now²
• FibroBiologics, Inc.Board member Feb 7, 2024 to now³
• TuHURA Biosciences, Inc./NVBoard member Apr 12, 2018 to now⁴
• TuHURA Biosciences, Inc./NVChief financial officer Jun 2, 2023 to Sep 1, 2023⁵
• TuHURA Biosciences, Inc./NVChief executive officer Nov 10, 2021 to Sep 1, 2023⁶
• TuHURA Biosciences, Inc./NVPresident Nov 10, 2021 to Sep 1, 2023⁶
• Kura OncologyBoard member Mar 26, 2015 to Jun 23, 2021⁷
• HERON THERAPEUTICS, INC. /DE/Chief financial officer Apr 24, 2017 to Dec 23, 2019⁸
• Aravive, Inc.Board member Oct 16, 2018 to Sep 13, 2019⁹
• Arena PharmaceuticalsChief financial officer Jan 3, 2006 to Dec 17, 2014¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TBTuHURA Biosciences, Inc./NV HURA68,902 shares¹¹$121.6K at $1.76Jun 1, 2023
• FFibroBiologics, Inc. FBLG7,500 shares¹²$7.2K at $0.96Feb 7, 2024
• ETEsperion Therapeutics ESPR0 shares¹³Jul 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2026Returned to company 85,153 shares of Esperion Therapeutics¹³
• May 28, 2026Granted 79,873 shares of Esperion Therapeutics¹⁴
• May 29, 2025Granted 5,280 shares of Esperion Therapeutics¹⁵
• Jun 1, 2023Granted 59,800 shares of TuHURA Biosciences, Inc./NV¹¹
• Aug 1, 2022Granted 400,145 shares of TuHURA Biosciences, Inc./NV¹⁶
• Feb 15, 2022Bought 55,000 shares at $0.47 of TuHURA Biosciences, Inc./NV¹⁷